"Master of Disaster" September 2-4, 2021 - Essen, Germany + ONLINE - "Master of Disaster"
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
»Master of Disaster« State of the Art Therapy and Complication Management in Gynecologic Oncology and Breast Cancer September 2– 4, 2021 Essen, Germany + ONLINE www.masterofdisaster.org
TABLE OF CONTENT
INHALTSVERZEICHNIS
Greeting Words . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
THURSDAY, SEPTEMBER 2, 2021
Pre-Program Breast Cancer . . . . . . . . . . . . . . . . . . . . . 6
Pre-Program Gynecologic Oncology . . . . . . . . . . . . . . 7
FRIDAY, SEPTEMBER 3, 2021
Main Program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
SATURDAY, SEPTEMBER 4, 2021
Main Program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Speakers, Chairs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
General Information . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Sponsors, Exhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . 18
IMPRINT ¡ IMPRESSUM
Editors ¡ Herausgeber
Prof. Dr. med. Sherko Kümmel
Interdisciplinary Breast Unit
Interdisziplinäres Brustkrebszentrum
Priv.-Doz. Dr. med. Philipp Harter
Prof. Dr. med. Dr. h.c. Andreas du Bois
Department of Gynecology and Gynecologic Oncology
Klinik für Gynäkologie und Gynäkologische Onkologie
Evang. Kliniken Essen-Mitte, Essen (Germany)
Layout and Setting ¡ Layout und Satz
Jörg Eickeler
Beratung Organisation Veranstaltung
Neanderstraße 20, 40233 Düsseldorf (Germany)
Tel. +49(0)211/3033224, Fax +49 (0)211/3033554
info@eickeler.org, www.eickeler.org
3GREETING WORDS GREETING WORDS
GRUSSWORT GRUSSWORT
Dear Colleagues, Liebe Kolleginnen und Kollegen,
Coming up for the eighth time in September 2021: zum achten Mal heißt es im September 2021 wieder:
»Master of Disaster«. After last years’ great success, we »Master of Disaster«. Wir knüpfen an den internationalen
continue our course: You are cordially invited to join us – Erfolg von letztem Jahr an: Sie sind ganz herzlich zur
live in Essen / Germany or online. Teilnahme eingeladen – live in Essen oder online.
The pre-program again gives you the opportunity to set Das Vorprogramm am Donnerstag bietet wieder die
your individual focus: We offer you Breast Surgery Möglichkeit, Ihren persönlichen Schwerpunkt zu setzen:
Workshops and a Surgical Workshop Gynecologic Wir bieten Workshops zur Brustchirurgie und einen
Oncology. OP-Workshop Gynäkologische Onkologie an.
In the main program on Friday and Saturday, outstanding Im Hauptprogramm am Freitag und Samstag referieren
representatives from our international and national herausragende Vertreter unserer internationalen und
cooperation partners will give their lectures. The chairs will nationalen Kooperationspartner. Die Moderatoren
moderate and discuss their contributions. begleiten die Vorträge und diskutieren sie.
Whether personally in Essen or online: We are looking Ob persönlich in Essen oder am Bildschirm: Wir freuen uns
forward to welcome you! darauf, Sie begrüßen zu dürfen!
Yours sincerely, Herzlichst Ihre
Prof. Dr. med. Sherko Kümmel PD Dr. med. Philipp Harter Prof. Dr. med. Sherko Kümmel PD Dr. med. Philipp Harter
Prof. Dr. med. Dr. h.c. Andreas du Bois Prof. Dr. med. Dr. h.c. Andreas du Bois
4 5PRE-PROGRAM PRE-PROGRAM
VORPROGRAMM VORPROGRAMM
PROGRAMM
THURSDAY, SEPTEMBER 2, 2021 THURSDAY, SEPTEMBER 2, 2021
1
BREAST CANCER SURGICAL WORKSHOP GYNECOLOGIC ONCOLOGY
Chair: P. Harter, J. Sehouli, S. Mahner
03.15–03.35 pm Plastic Reconstruction in Vulvar Cancer
ANZEICHNUNGSKURS BRUSTCHIRURGIE
Surgery
„MALEN NACH ZAHLEN“ [in German!]
S. Prader
11.30–11.50 am Verschiedene Reduktions- 03.40–04.00 pm Technique of Pelvic En-bloc Resection
techniken von der Anzeichnung B. Ataseven
bis zur OP, u.a. KEM-Methode
S. Kümmel 04.05–04.25 pm Diaphragmatic Surgery in Ovarian Cancer
P. Harter
11.50–12.10 pm Die komplizierte BCT (inkl. B-Plastik)
H. Rotthaus 04.30–04.50 pm Peri-operative Management for Ovarian
Cancer Surgery
12.10–12.30 pm Die richtige Implantat- und C. Fotopoulou
Lageauswahl bei Rekonstuktion sowie
ästhetischer Agumentation 04.55–05.15 pm Management of Bowel Anastomosis
M. Warm O. Zivanovic
12.30–12.50 pm Rekonstruktion des Mamillen-Areola- 05.20–05.40 pm Radical Hysterectomy 2021
Komplex – Techniken, Tipps und Tricks M. Z. Muallem
B. Behr 05.45–06.05 pm Technique and Indication for Sentinel
Lymphadenectomy in Gynecology Cancer
N. Abu-Rustum
1
INTERNATIONAL SESSION 06.10–06.30 pm Surgical Management of Extraabdominal
Chair: M. Lehnhardt, S. Kümmel Disease in Ovarian Cancer
G. Aletti
01.00–01.15 pm Reduction Plasty: Marking – Tips and Tricks
F. Reyal
01.15–01.30 pm Implant from Augmentation to
Reconstruction: Marking – Tips and Tricks
A. Rancati
01.30–01.45 pm Nipple Reconstruction – Different Ways ...
B. Behr
MASTER OF DISASTER – CASES AND HOW TO SOLVE
1
PROBLEMS
Chair: M. Lehnhardt, S. Kümmel
02.00–02.10 pm Granulomatous Mastitis
O. Chiari
02.10–02.20 pm Implant: Infection and Necrosis
B. Behr
02.20–02.30 pm Too High, Too Low After Implant-based
Reconstruction: Cranial Dislocation or
Bottoming Out
K. Brunnert
02.30–02.40 pm Iatrogenic Synmastia
J.-U. Blohmer
02.40–02.50 pm Wrinkling and the Jumping Breast (Animation
Deformity): Definition, Risks and Prevention
H. Harrach
6 1) in the lecture hall in Essen + online live stream 7MAIN PROGRAM MAIN PROGRAM
HAUPTPROGRAMM HAUPTPROGRAMM
PROGRAMM
FRIDAY, SEPTEMBER 3, 2021 FRIDAY, SEPTEMBER 3, 2021
BREAST SESSION } Maintenance Therapy in Newly Diagnosed
Ovarian Cancer
08.00–09.00 am Breast Surgery – Video Session with Live
A. González Martín; Panel: C. Marth,
Moderation and Discussion
E. Pujade-Lauraine, J. Ledermann
Chair: S. Kümmel F. Reyal, K. Brunnert
} Treatment of recurrent Ovarian Cancer:
} New OP Procedures
Definition of Goals and Populations
} Tips and Tricks for Solving Complications
J. Ledermann; Panel: A. González Martín,
and Difficult Cases
N. Colombo, E. Pujade-Lauraine
09.00–10.00 am Breast Cancer Therapies 2021 – } Tumorbiology and Biomarkers: Stage and
New Options and New Challenges Residuals + Histo Type + BRCA
Chair: S. Kümmel + HRD and Many More to Come
} Talk: Early Breast Cancer E. Pujade-Lauraine; Panel: C. Marth, I. Vergote,
P. Schmid A. González Martín
} Talk: Metastatic Breast Cancer: Tucatinib a supported by GlaxoSmithKline GmbH & Co. KG
New Standard?
N. Harbeck OVARIAN CANCER: SURGICAL ISSUES
} Discussion and Conclusion Chair: A. du Bois, C. Fotopoulou
supported by Seagen Germany GmbH
12.30–12.45 pm How to Select Patients for Neoadjuvant
10.00–10.15 am Break Therapy
D. Chi
GYN-ONCOLOGY SESSION 12.50–01.05 pm How to Select Patients for Upfront Surgery
S. Mahner
10.15–10.45 am Highlights and Current Studies in
Gynecological Oncology 01.10–01.25 pm If We Opt for NACT, Do We Need Interval
Chair: A. du Bois Debulking in Any Case?
} Ongoing Trials in Gynecologic Oncology I. Vergote
H.-J. Lück 01.30–02.00 pm The Role of Laparoscopy in Ovarian
} Role of Systemic Therapy in Cervical Cancer Neoplasm Surgery:
C. Grimm } The Case of Staging – Which Patients,
10.45–12.15 pm 35 Years Dedicated to Gynecological Which Tumors?
Oncology … and the Best is Yet to Come P. Kannisto
Chair: P. Harter, J. Sehouli } The Case of Interval Debulking – Which
} Excellence Needs Structures: Center, Study Patients, Which Tumors?
Group, European Network, Global A. Fagotti
Network and Structures 02.05–02.20 pm The Role of Leadership in Building Up
I. Vergote; Panel: N. Colombo, L. Chiva Structures and Improving Care in
} Timing and Radicality of Ovarian Cancer Gynecological Oncology in Europe
Surgery P. Harter
L. Chiva; Panel: I. Vergote, C. Marth, N. Colombo
} Second Chance for Surgery? Surgery in 02.25–02.55 pm Break
Recurrent Ovarian Cancer – Surgery and
Tumor Biology OVARIAN CANCER: SYSTEMIC THERAPY ISSUES
C. Marth; Panel: J. Ledermann, I. Vergote, L. Chiva Chair: N. Concin, J. Sehouli
} First-line Chemotherapy in Ovarian Cancer
N. Colombo; Panel: E. Pujade-Lauraine, 03.00–03.20 pm State-of-the-Art Lecture: 1st Line Therapy
A. González Martín, J. Ledermann A. González Martín
03.25–03.40 pm How to Identify Patients Not Fit for
Combination Chemotherapy
F. Hilpert
8 Main program: in the lecture hall in Essen + online live stream 9MAIN PROGRAM MAIN PROGRAM
HAUPTPROGRAMM HAUPTPROGRAMM
PROGRAMM
FRIDAY, SEPTEMBER 3, 2021 SATURDAY, SEPTEMBER 4, 2021
03.45–04.00 pm How to Identify Patients Not Suitable for UPDATE ON SYSTEMIC TREATMENT IN BREAST CANCER:
Bevacizumab – Complication Management WHAT IS PROVEN, WHAT IS COMING NEXT?
and Treatment Monitoring for Chairs: S. Kümmel, P. Schmid
Antiagiogenesis
09.00–09.20 am Triple-negative Breast Cancer – From Early
I. Ray-Coquard
to Metastatic Disease
04.05–04.20 pm How to Identify Patients Not Suitable or Not P. Schmid
in Need for PARPi – the Role of Molecular
09.20–09.40 am HER2/neu Positive Disease – From Early to
and Genetic Testing
Metastatic Disease
E. Pujade-Lauraine
J. Cortes
04.25–04.45 pm Break 09.40–09.55 am HR + Early Breast Cancer – Who Needs
Chemotherapy?
UTERINE CANCER: SPECIAL ISSUES O. Gluz
Chair: B. Ataseven, I. Vergote 09.55–10.10 am HR + Metastatic Breast Cancer – Which
04.45–05.00 pm State-of-the-Art Lecture: Fertility Sparing in Drugs and When?
Gynecological Cancer N. Harbeck
N. Colombo 10.10–10.25 am Live Dicussion and Live Chat
05.05–05.20 pm How to Treat Fragile Patients with FIGO
Stage I/II Endometrial Cancer Not Fit Enough 10.25–10.45 am Break
for Surgery
NN LOCAL THERAPY – AXILLA SURGERY
Chairs: W. Weber, J. Heil, A. Caudle, F. Reyal
05.25–05.40 pm Treatment of Relapsed Uterine Cancer –
Update Systemic Therapy 10.45–10.55 am TAD: KEM Algorithm and Challenges after
C. Marth SENTA Data
M. Reinisch
05.45–06.00 pm Selection for and Complication Management
in Surgical Therapy for Recurrent Uterine 10.55–11.10 am TAD: International Perspective
Cancer A. Caudle
L. Chiva 11.10–11.20 am LN Surgery in Case of Relapse –
06.05–06.20 pm How to Monitor and Treat Complications of KEM Algorithm
Immunotherapy S. Bruzas
D. Lorusso 11.20–11.35 am LN Surgery in Case of Relapse –
International Perspective
RECURRENT OVARIAN CANCER F. Reyal
Chair: F. Heitz, N. Colombo
11.35–11.50 am Surgical Intervention in Lymphedema
06.25–06.40 pm State-of-the-Art Lecture: Treatment Choice B. Behr
in Recurrent Ovarian Cancer – the Role of 11.50–12.05 pm Live Dicussion and Live Chat
Prior Treatment
J. Ledermann
06.45–07.00 pm Cytoreductive Surgery in Recurrent Ovarian
Cancer, Risk Factors for Complications
J. Sehouli
07.05–07.20 pm Ileus/Subileus: How to Decide For or Against
Surgical Intervention
P. Alesina
10 Main program: in the lecture hall in Essen + online live stream 11MAIN PROGRAM SPEAKERS, CHAIRS
HAUPTPROGRAMM REFERENTEN, VORSITZE
PROGRAMM
SATURDAY, SEPTEMBER 4, 2021 Abu-Rustum, Prof. Dr. Nadeem R., Gynecology Service, Department of
Surgery, Memorial Sloan Kettering Cancer Center, New York, NY (USA)
RECONSTRUCTIVE SURGERY Alesina, Dr. Pier F., Department of Gynecology and Obstetrics,
Chairs: A. Pusic, S. Kümmel Gemelli Molise, Catholic University of the Sacred Heart, Campobasso (I)
12.05–12.20 pm Antibiotic Stewardship: What to Use in Aletti, Dr. Giovanni, Innovative Therapeutic Strategies in Ovarian
Which Surgical Method – from BET to Cancer Unit, IEO, Milano (I)
Heterologous Reconstruction. What is Ataseven, PD Dr. med. Beyhan, Department of Gynecology and
Proven and What is Voodoo? Gynecologic Oncology, Evang. Kliniken Essen-Mitte, Essen (D)
M. Thill
Behr, Prof. Dr. med. Björn, Department of Plastic Surgery and
12.20–12.35 pm A Modified Reduction Plasty with Plastic-reconstructive Surgery, BG University Hospital Bergmannsheil
Craniomedial Pedicled MAC: Bochum (D)
The KEM Method with Data, Facts and
Figures Blohmer, Prof. Dr. med. Jens-Uwe, Department of Gynecology and
M. Reinisch Breast Center, Charité – Universitätsmedizin Berlin, Campus Charité
Mitte, Berlin (D)
12.35–01.05 pm For Which Patients Does Prophylactic
Surgery Make Sense? du Bois, Prof. Dr. med. Dr. h.c. Andreas, Department of Gynecology
} American Perspective and Gynecologic Oncology, Evang. Kliniken Essen-Mitte, Essen (D)
A. Pusic Brunnert, Dr. med. Klaus, Breast Center, Klinik für Senologie,
} German Perspective Osnabrück (D)
J. Heil
Bruzas, Simona, Interdisciplinary Breast Center, Evang. Kliniken Essen-
01.05–01.20 pm Live Dicussion and Live Chat Mitte, Essen (D)
01.20–01.50 pm Break Caudle, Dr. Abigail S., Department of Breast Surgical Oncology,
Houston, TX (USA)
SPECIAL TOPIC: OLIGOMETASTATIC BREAST CANCER Chi, Dr. Dennis S., Gynecology Service, Department of Surgery,
Chairs: K. Herrmann, W. Weber, K. Ferentinos, M. Reinisch Memorial Sloan Kettering Cancer Center, New York, NY (USA)
01.50–02.05 pm Diagnostic Challenges and Pitfalls Chiari, Dr. med. Ouafaa, Interdisciplinary Breast Center, Evang. Kliniken
K. Herrmann Essen-Mitte, Essen (D)
02.05–02.20 pm Local Radiotherapy in OMD – New Chiva de Agustin, Dr. Luis, Department of Obstetrics and Gynecology,
Techniques Clinica Universidad de Navarra, Madrid (E)
K. Ferentinos
Colombo, Prof. Dr. Nicoletta, Department of Medicine and Surgery,
02.20–02.35 pm Impact of Surgery in OMD Università Milano-Bicocca, European Institute of Oncology, Milano (I)
W. Weber
Concin, Prof. Dr. med. Nicole, Department of Gynecology, Medizinische
02.35–02.50 pm Live Dicussion and Live Chat Universität Innsbruck, Innsbruck (A) + Department of Gynecology and
Gynecologic Oncology, Evang. Kliniken Essen-Mitte, Essen (D)
OXFORD DEBATE: PRE- OR SUBPECTORAL IMPLANT
RECONSTRUCTION? Cortes, Dr. Javier, IOB Institute of Oncology, Madrid and Barcelona (E)
Chairs: W. Weber Fagotti, Prof. Dr. Anna, Gynecology and Obstetrics, Catholic
02.50–03.05 pm PRO Subpectoral University of the Sacred Heart, Roma (I)
S. Potter Ferentinos, Dr. Konstantinos, Department of Radiotherapy
03.05–03.20 pm PRO Prepectoral Oncology, German Oncology Center, Limassol (CY)
S. Kümmel Fotopoulou, Prof. Dr. med. Christina, Department of Gynecology with
Center for Oncological Surgery, Charité – Universitätsmedizin Berlin,
03.20 pm Closing Words and Farewell Campus Virchow-Klinikum, Berlin (D) + Obstetrics and Gynecology,
Gynecologic Oncology, Hammersmith Hospital, Queen Charlotte’s and
Chelsea Hospital, London (UK)
12 Status: August 2021; may be subject to change 13SPEAKERS, CHAIRS SPEAKERS, CHAIRS
REFERENTEN, VORSITZE REFERENTEN, VORSITZE
Gluz, PD Dr. med. Oleg, Breast Center Niederrhein, Evangelisches Potter, Dr. Shelley, Bristol Breast Care Centre, Southmead Hospital,
Krankenhaus Bethesda, Mönchengladbach (D) Bristol (UK)
González Martín, Dr. Antonio, Department of Medical Oncology, Prader, Dr. med. univ. Sonia, Department of Gynecology, Hospital
Clinica Universidad de Navarra, Madrid (E) Brixen, Brixen (I)
Grimm, Prof. PD. Dr. med. Christoph, Department of Gynecology and Pujade-Lauraine, Prof. Eric, Medical Oncology Department, CHU Paris
Gynecologic Oncology, Universitätsklinik für Frauenheilkunde, Centre Hôpital Hôtel-Dieu; Université de Paris Descartes, Paris (F)
Medizinische Universität, Wien (A) Pusic, Dr. Andrea Louise, Department of Plastic and Reconstructive
Harbeck, Prof. Dr. med. Nadia, Breast Center and Oncological Clinic, Surgery, Brigham and Women’s Hospital, Boston, MA (USA)
Frauenklinik der Universität München, Campus Innenstadt + Campus Rancati, Dr. Alberto, Department of Oncoplastic Surgery, Institute
Großhadern, München (D) Oncologico Henry Moore, Buenos Aires (ARG)
Harrach, Hakima, Interdisciplinary Breast Center, Evang. Kliniken Essen- Ray-Coquard, Prof. Dr. Isabelle, Department of Oncology, University
Mitte, Essen (D) Claude Bernard Lyon Est, Lyon (F)
Harter, PD Dr. med. Philipp, Department of Gynecology and Reinisch, Dr. med. Mattea, Interdisciplinary Breast Center, Evang.
Gynecologic Oncology, Evang. Kliniken Essen-Mitte, Essen (D) Kliniken Essen-Mitte, Essen (D)
Heil, Prof. Dr. med. Jörg, Breast Center, Women’s Health and Reyal, Prof. Dr. Fabien, Department of Breast Cancer, Gynecologic
Obstetrics, Universitätsklinikum Heidelberg, Heidelberg (D) Cancer and Reconstructive Surgery, Université Paris Descartes, Paris (F)
Heitz, PD Dr. med. Florian, Department of Gynecology and Rotthaus, Dr. med. Horst, Interdisciplinary Breast Center, Evang.
Gynecologic Oncology, Evang. Kliniken Essen-Mitte, Essen (D) Kliniken Essen-Mitte, Essen (D)
Herrmann, Prof. Dr. med. Ken, Clinic of Nuclear Medicine, Schmid, Prof. Dr. med. Peter, Barts Cancer Institute, Centre of
Universitätsklinikum Essen, Essen (D) Excellence Queen Mary University, London (UK)
Hilpert, Prof. Dr. med. Felix, Mamma Center Hamburg, Krankenhaus Sehouli, Prof. Dr. med. Dr. h.c. Jalid, Department of Gynecology with
Jerusalem, Hamburg (D) Center for Oncological Surgery, Charité – Universitätsmedizin Berlin,
Kannisto, Prof. Dr. Päivi, Department of Obstetrics and Gynecology, Campus Virchow-Klinikum, Berlin (D)
Lund University, Lund (S) Thill, Prof. Dr. med. Marc, Department of Gynecology and Gynecologic
Kümmel, Prof. Dr. med. Sherko, Interdisciplinary Breast Center, Evang. Oncology, Agaplesion Markus Krankenhaus, Frankfurt/Main (D)
Kliniken Essen-Mitte, Essen (D) Vergote, Prof. Dr. Ignace, Department of Gynecology and Obstetrics,
Ledermann, Prof. Dr. Jonathan A., UCL Cancer Institute, University Universitair Ziekenhuis Leuven, Leuven (B)
College London, London (UK) Warm, Prof. Dr. med. Mathias, Breast Center Köln-Holweide, Köln (D)
Lehnhardt, Prof. Dr. med. Marcus, Department of Plastic surgery and Weber, Prof. Dr. med. Walter Paul, Breast Center, Universitätsspital,
Severe Burn Injury Center, Sarcoma Center, BG Universitätsklinikum Basel (CH)
Bergmannsheil, Bochum (D)
Zivanovic, Dr. Oliver, Gynecology Service, Department of Surgery,
Lorusso, Dr. Domenica, Department of Gynecology and Oncology, Memorial Sloan Kettering Cancer Center, New York, NY (USA)
National Cancer Center, Milano (I)
Lück, Prof. Dr. med. Hans-Joachim, Gynäkologisch Onkologische Praxis
Hannover, Hannover (D)
Mahner, Prof. Dr. med. Sven, Women's Health and Obstetrics,
Universitätsklinikum München, Campus Innenstadt + Campus
Großhadern, München (D)
Marth, Prof. Dr. med. Christian, Gynecology and Obstetrics,
Universitätsklinikum Innsbruck, Innsbruck (A)
Muallem, PD Dr. med. Dr. med. (syr) Mustafa Zelal, Department of
Gynecology and Oncologic Surgery, Charité – Universitätsmedizin
Berlin, Campus Virchow-Klinikum, Berlin (D)
14 15GENERAL INFORMATION GENERAL INFORMATION
ALLGEMEINE INFORMATIONEN ALLGEMEINE INFORMATIONEN
DATE ¡ DATUM INFORMATION, ORGANIZER ¡
September 2–4, 2021 INFORMATION, VERANSTALTER
} September 2, 2021: Pre-Program ¡ Vorprogramm Jörg Eickeler
} September 3 and 4, 2021: Main Program ¡ Hauptprogramm Beratung Organisation Veranstaltung
Neanderstraße 20, 40233 Düsseldorf (Germany)
CONFERENCE VENUE ¡ VERANSTALTUNGSORT Tel. +49 (0)211 / 30 33 224, Fax +49 (0)211 / 30 33 554
Hotel Franz service@eickeler.org, www.eickeler.org
Steeler Straße 261
45138 Essen (Germany) EVENT WEBSITE ¡ VERANSTALTUNGS-WEBSITE
www.hotel-franz.de www.masterofdisaster.org
SCIENTIFIC BOARD ¡ WISSENSCHAFTL. LEITUNG CONGRESS LANGUAGE ¡ KONGRESSSPRACHE
Prof. Dr. med. Sherko Kümmel English ¡ Englisch
Interdisciplinary Breast Center
Priv.-Doz. Dr. med. Philipp Harter ACCREDITATION ¡ ZERTIFIZIERUNG
Prof. Dr. med. Dr. h.c. Andreas du Bois Pre-program Breast Surgery: 2 CME Points [on-site 2 additional]
Department of Gynecology and Gynecologic Oncology Pre-Program Gynecologic Oncology: 3 CME Points
Main Program: 18 CME Points [FRI 11 + SAT 7]
ONLINE
SCIENTIFIC COMMITTEE BREAST ¡
WISSENSCHAFTLICHES KOMITEE BRUST REGISTRATION ¡ ANMELDUNG = FREE
SCIENTIFIC CHAIR: You can find the registration – both for on-site as well as
Prof. Dr. med. Sherko Kümmel, Interdisciplinary Breast Center, online participation – at the website.
Evang. Kliniken Essen-Mitte, Essen (Germany)
Die Anmeldung – sowohl für Teilnahme vor Ort als auch Online-
VIZE SCIENTIFIC CHAIR: Teilnahme – finden Sie auf der Website.
Dr. med. Mattea Reinisch, Interdisciplinary Breast Center, Evang.
Kliniken Essen-Mitte, Essen (Germany)
www.masterofdisaster.org Registration
SCIENTIFIC BOARD:
Prof. Dr. med. Björn Behr, Department of Plastic Surgery, BG PARTICIPATION FEES TEILNAHMEGEBÜHREN
Universitätsklinikum Bergmannsheil Bochum (Germany) + Department
of Surgery, Evang. Kliniken Essen-Mitte, Essen (Germany); Pre-Program Breast Cancer (THU) ON-SITE: EUR 50
Prof. Dr. med. Jens-Uwe Blohmer, Department of Gynecology and Pre-Program Gyn. Oncology (THU) ON-SITE: EUR 50
Breast Center, Charité – Universitätsmedizin Berlin, Campus Charité Main Program (FRI + SAT) ON-SITE: EUR 75
Mitte, Berlin (Germany); Dr. Abigail S. Caudle, Department of Breast
Surgical Oncology, Houston, TX (USA); Prof. Dr. med. Jörg Heil, ONLINE PARTICIPATION IS FREE OF CHARGE!
Breast Center, Women’s Health and Obstretrics, Universitätsklinikum
Heidelberg, Heidelberg (Germany); Dr. Andrea L. Pusic, MD,
Division of Plastic and Reconstructive Surgery, Brigham and Women’s
Hospital, Boston, MA (USA); Prof. Dr. med. Peter Schmid, Barts PLEASE NOTE: HINWEIS:
Cancer Institute, Centre of Excellence Queen Mary University, London All pandemic guidelines Am Veranstaltungsort
(United Kingdom); Prof. Dr. Fabien Reyal, Breast Cancer, (valid in September) will be werden alle (im September
Gynecologic Cancer und Reconstructive Surgery, Department of implemented at the gültigen) Pandemie-
Surgery, Institut Curie; Université Paris Descartes, Paris (France);
conference venue! Auflagen umgesetzt!
Prof. Dr. med. Walter Paul Weber, Breast Center, Universitätsspital
Basel (Switzerland) Entry only with proof: Einlass nur bei Nachweis:
vaccinated, tested, or geimpft, getestet oder
recovered genesen
16 17SPONSORS, EXHIBITORS SPONSORS, EXHIBITORS
SPONSOREN, AUSSTELLER SPONSOREN, AUSSTELLER
GlaxoSmithKline GmbH & Co. KG Amgen GmbH
81675 München 80992 München
EUR 50.000,– EUR 5.000,–
Seagen Germany GmbH Pfizer Pharma GmbH
80539 München 10785 Berlin
EUR 30.000,– EUR 5.000,–
AstraZeneca GmbH Pierre Fabre Pharma GmbH
22880 Wedel 79111 Freiburg
EUR 20.000,– EUR 5.000,–
Lilly Deutschland GmbH Sirius Medical B.V.
61352 Bad Homburg 5656 AE Eindhoven (NL)
EUR 20.000,– EUR 5.000,–
MSD Sharp & Dohme GmbH Somatex Medical Technologies GmbH
85540 Haar 14199 Berlin
EUR 20.000,– EUR 4.000,–
Roche Pharma AG Eisai GmbH
79639 Grenzach-Wyhlen 60528 Frankfurt/Main
EUR 15.000,– EUR 2.500,–
Daiichi-Sankyo Deutschland GmbH Mersana Therapeutics, Inc.
81379 München Cambridge, MA 02139 (USA)
EUR 10.000,– USD 2.500,–
STADA Arzneimittel AG Novartis Pharma GmbH
61118 Bad Vilbel 90429 Nürnberg
EUR 10.000,– EUR 2.000,–
Stryker GmbH & Co. KG Pfm Medical AG
47228 Duisburg 50996 Köln
EUR 10.000,– EUR 2.000,–
Medtronic GmbH PharmaMar GmbH
40670 Meerbusch 10623 Berlin
EUR 8.000,– EUR 2.000,–
Polytech Health & Aesthetics GmbH Bess AG
64807 Dieburg 14167 Berlin
EUR 8.000,– EUR 1.500,–
Exact Sciences Deutschland GmbH Riemser Pharma GmbH
51103 Köln 17489 Greifswald
EUR 6.500,– EUR 500,–
Gilead Sciences GmbH
82152 Martinsried VIELEN DANK FÜR DIE UNTERSTÜTZUNG!
Sponsoring und Ausstellung. Die Beiträge werden genutzt für: Veranstaltungsorganisation und
EUR 6.000,– Marketing; Raummiete, Technik (Websites, Contentproduktion, Veranstaltungstechnik und
Streaming), Catering, Reisekosten und Honorare der Referenten.
18 19»Master of Disaster«
State of the Art Therapy and Complication
Management in Gynecologic Oncology
and Breast Cancer
September 1– 3, 2022
Essen, Germany
www.masterofdisaster.orgYou can also read
